A detailed history of Ifp Advisors, Inc transactions in Organon & Co. stock. As of the latest transaction made, Ifp Advisors, Inc holds 5,661 shares of OGN stock, worth $83,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,661
Previous 5,400 4.83%
Holding current value
$83,386
Previous $101,000 15.84%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$17.45 - $21.96 $4,554 - $5,731
261 Added 4.83%
5,661 $117,000
Q1 2024

Jul 30, 2024

BUY
$13.78 - $18.8 $12,470 - $17,014
905 Added 20.13%
5,400 $101,000
Q4 2023

Jan 09, 2024

BUY
$10.95 - $17.32 $36,408 - $57,589
3,325 Added 284.19%
4,495 $64,000
Q3 2023

Oct 12, 2023

SELL
$16.59 - $23.77 $564 - $808
-34 Reduced 2.82%
1,170 $20,000
Q2 2023

Aug 04, 2023

SELL
$19.27 - $24.63 $28,731 - $36,723
-1,491 Reduced 55.32%
1,204 $25,000
Q1 2023

Apr 18, 2023

SELL
$21.42 - $32.08 $59,611 - $89,278
-2,783 Reduced 50.8%
2,695 $63,000
Q4 2022

Feb 07, 2023

SELL
$23.31 - $28.61 $25,431 - $31,213
-1,091 Reduced 16.61%
5,478 $254,000
Q3 2022

Nov 08, 2022

SELL
$23.4 - $34.25 $3,697 - $5,411
-158 Reduced 2.35%
6,569 $304,000
Q2 2022

Sep 06, 2022

BUY
$31.66 - $38.9 $212,976 - $261,680
6,727 New
6,727 $306,000
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $212,976 - $261,680
-6,727 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$30.45 - $39.36 $159,070 - $205,616
5,224 Added 347.57%
6,727 $234,000
Q1 2022

Aug 08, 2022

SELL
$30.45 - $39.36 $548 - $708
-18 Reduced 1.18%
1,503 $52,000
Q4 2021

Jan 12, 2022

SELL
$28.67 - $37.13 $23,652 - $30,632
-825 Reduced 35.17%
1,521 $85,000
Q3 2021

Oct 06, 2021

BUY
$28.63 - $35.64 $9,591 - $11,939
335 Added 16.66%
2,346 $123,000
Q2 2021

Jul 13, 2021

BUY
$28.45 - $38.0 $57,212 - $76,418
2,011 New
2,011 $44,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.